Apr 23, 2021 / 12:00PM GMT
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director
Good afternoon, good morning, everyone, and welcome to this Annual General Meeting of Hikma Pharmaceuticals 2021. Peter Speirs, the Secretary of the Board is the only one in London in the meeting room at the moment, I want to hand it over to him to go through the agenda. Peter?
Peter A. Speirs - Hikma Pharmaceuticals PLC - Company Secretary
Thank you, Siggi. Good afternoon, ladies and gentlemen. In accordance with the company's Articles of Association, I confirm that there is a quorum of shareholders in the room. The shareholders present have confirmed that they are content for me to perform the role of Chairman of the meeting. Today, we'll focus on the formal aspects of the Annual General Meeting, which will form 3 parts.
Firstly, I will explain the procedures for the meeting. Secondly, there will be an opportunity to address shareholders' questions. Thirdly, we will consider the resolutions that have been proposed to shareholders.
Section 1, the procedures. At
Hikma Pharmaceuticals PLC Annual Shareholders Meeting Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers